These results reveal that bone marrow cell-derived MYDGF was both sufficient and necessary to regulate hepatic inflammation, lipogenesis, hepatic steatosis, and metabolic disorders in NAFLD mice. Here, MYDGF is linked to Hepatic steatosis.